Production (Stage)
InterCure Ltd.
INCR
$1.52
$0.021.33%
NASDAQ
| 12/31/2024 | 09/30/2024 | 12/31/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -20.77% | -22.29% | -36.30% | -1.49% | 10.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.77% | -22.29% | -36.30% | -1.49% | 10.10% |
| Cost of Revenue | 4.88% | 2.87% | -15.08% | 25.54% | 29.99% |
| Gross Profit | -98.89% | -98.91% | -63.83% | -32.24% | -12.63% |
| SG&A Expenses | 41.04% | 38.34% | -21.97% | -3.51% | 24.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2,451.39% | 2,402.94% | -97.99% | -41.33% | 317.96% |
| Total Operating Expenses | 37.12% | 34.49% | -38.99% | 14.54% | 34.93% |
| Operating Income | -765.80% | -749.19% | 60.18% | -70.29% | -73.17% |
| Income Before Tax | -44.02% | -41.25% | -232.99% | -98.26% | -91.73% |
| Income Tax Expenses | -523.79% | -515.71% | 112.72% | -153.06% | -67.69% |
| Earnings from Continuing Operations | -11.24% | -9.10% | -685.52% | -77.95% | -99.43% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 1,145.60% | 1,121.63% | -95.90% | 554.43% | 108.32% |
| Net Income | -6.26% | -4.22% | -459.01% | -71.39% | -98.55% |
| EBIT | -765.80% | -749.19% | 60.18% | -70.29% | -73.17% |
| EBITDA | -1,167.41% | -1,531.07% | 73.88% | -59.27% | -63.16% |
| EPS Basic | -8.30% | -6.20% | -463.70% | -74.40% | -98.82% |
| Normalized Basic EPS | -410.00% | -398.99% | 26.42% | -- | -91.60% |
| EPS Diluted | -8.35% | -6.35% | -463.89% | -73.65% | -98.76% |
| Normalized Diluted EPS | -410.00% | -398.99% | 26.00% | -- | -91.13% |
| Average Basic Shares Outstanding | -1.87% | -1.87% | -1.31% | 11.62% | 21.61% |
| Average Diluted Shares Outstanding | -1.87% | -1.87% | -1.78% | 8.43% | 15.21% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |